EP2907506
Aðferð til að framleiða lyfjasamsetningu á formi forðataflna sem innihalda pírfenidón og notkun þeirra í afturbata langvinnrar nýrnastarfsbilunar, brjóstaherpingar og lifrartrefjunar hjá manneskjum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.7.2012EP application number:
15161929.3
EP translation filed:
6.2.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
12.7.2032Expiry date:
12.7.2026Next due date:
31.7.2026
Title:
METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION IN THE FORM OF EXTENDED-RELEASE TABLETS CONTAINING PIRFENIDONE AND USE THEREOF IN THE REGRESSION OF CHRONIC RENAL INSUFFICIENCY, BREAST CAPSULAR CONTRACTURE AND HEPATIC FIBROSIS IN HUMANS
Timeline
Today
13.7.2012EP application
6.2.2018Translation submitted
15.3.2018Registration published
12.7.2026Expires
Owner
Name:
CELL THERAPY AND TECHNOLOGY, S.A. DE C.V.Address:
Calzada de la Bombas n°128, Bodega 1, Col. Ex-Hacienda Coapa Delegacion Coyoacan, CP 04980, Federal District, MX
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 26.7.2018
Expires: 12.7.2019
Payer: Tego ehf.
Number: 8
Paid: 26.7.2019
Expires: 12.7.2020
Payer: Tego ehf.
Number: 9
Paid: 10.7.2020
Expires: 12.7.2021
Payer: Tego ehf.
Number: 10
Paid: 20.7.2021
Expires: 12.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 21.6.2022
Expires: 12.7.2023
Payer: Patice ehf.
Number: 12
Paid: 21.6.2023
Expires: 12.7.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 18.6.2024
Expires: 12.7.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 4.7.2025
Expires: 12.7.2026
Payer: Árnason Faktor ehf.